Aptivus is used in the treatment of the infection caused by the Human Immunodeficiency Virus (HIV-1). HIV-1 is the main virus responsible for the development of Acquired Immunodeficiency Syndrome (AIDS).
Aptivus contains the active ingredient Tipranavir. Tipranavir belongs to a group of antiretroviral medicines called protease inhibitors.
Tipranavir helps control HIV infection by inhibiting or interfering with the protease enzyme that the HIV virus needs to multiply.
Aptivus does not cure or prevent HIV-1 infection or AIDS, but it does hinder the growth of HIV-1.
Aptivus is prescribed for use in combination with low-dose Ritonavir and other antiretrovirals.
When these medicines are taken with Aptivus, the growth of HIV-1 is hindered more effectively.
Aptivus has not been shown to reduce the incidence or frequency of the illnesses caused by AIDS. It is important for you to continue seeing your doctor regularly.
Aptivus does not reduce the risk of or prevent transmission of HIV-1 to others through sexual contact or blood contamination.
Do not take Aptivus if you are allergic to tipranavir or any of the other ingredients in Aptivus.
These ingredients are listed in full at the end of this leaflet. This includes rare inherited conditions of fructose intolerance.
If you are not sure if you have these allergies, you should raise those concerns with your doctor.
Do not take Aptivus if you have moderate to severe liver problems.
Do not take Aptivus if you are taking certain other medicines which include:
If you are not sure whether you should start taking Aptivus, talk to your doctor.
Do not take Aptivus after the expiry date on the carton or bottle has passed.
Do not take Aptivus if the packaging is torn or shows signs of tampering.
It is essential that your doctor knows your medical history before prescribing Aptivus.
Before taking Aptivus, you must tell your doctor if you have, or have had, any of the following conditions:
If you are not sure if you have, or have had, any of these conditions, you should raise those concerns with your doctor.
Before using Aptivus, it is important to tell your doctor if you are taking any other medicines, obtained with or without a doctor's prescription.
In particular, you should tell your doctor if you are taking:
These medicines may be affected by Aptivus, or may affect how well it works. You may need different amounts of the medicine, or you may need to take different medicines.
Your doctor or pharmacist will advise you.
As Aptivus may reduce the effectiveness of oral contraceptives, talk to your doctor about alternative methods of contraception.
Ask for your doctor's advice if you are pregnant, or likely to become pregnant during your course of medication.
Your doctor will discuss the risks and benefits of taking Aptivus during pregnancy.
You should ask for your doctor's advice if you wish to breastfeed during your use of Aptivus.
Breastfeeding is not recommended for a HIV infected woman as there is a risk of passing the HIV-1 virus to your baby.
Aptivus is not recommended for use in children less than 2 years of age.
Safety and effectiveness in children less than 2 years of age have not been established.
It is essential that you take Aptivus with low-dose Ritonavir.
Follow all directions given to you by your doctor carefully.
They may differ from the information contained in this leaflet.
If you do not understand the instructions, ask your doctor or pharmacist for help.
The recommended dose for adults is two Aptivus soft capsules together with 200 mg of ritonavir, twice daily (i.e. at regular 12-hour intervals at about the same time each day - morning and night).
The recommended dose of Aptivus and ritonavir for children 2 years of age or older will be determined by your doctor based on the weight and size of your child. Your doctor or pharmacist will be able to help you determine how and at what time you should give Aptivus to your child.
Aptivus capsules should be swallowed whole.
Do not chew the capsules.
Aptivus taken with low-dose Ritonavir should be taken with food.
It is important to take Aptivus as directed.
If you miss a dose, take it as soon as you remember. However, if you remember when it is almost time for your next dose, take only your usual dose at that time.
Do not take a double dose to make up for the dose you missed.
If you are not sure what to do, talk to your doctor or pharmacist.
If you have trouble remembering to take your medicine, ask your pharmacist for some hints.
Immediately telephone your doctor, pharmacist or Poisons Information Centre (telephone 13 11 26) for advice, or go to Emergency at your nearest hospital if you think that you or anyone else may have taken too much Aptivus. Do this even if there are no signs of discomfort or poisoning. You may need urgent medical attention.
If you are about to be started on any new medicine, tell your doctor and pharmacist that you are taking Aptivus.
Not all medicines can be safely taken with Aptivus. Some medicines will require a change in dosage or close monitoring if taken with Aptivus.
Tell all doctors, dentists and pharmacists who are treating you that you are taking Aptivus.
Contact your doctor if you experience any symptoms of liver problems, such as loss of appetite, nausea, vomiting, jaundice (yellowing of the skin and/or eyes), dark coloured urine, pale coloured stools, pain/ache or sensitivity to touch in your right abdominal area (below your ribs).
These could be signs of serious liver dysfunction which your doctor will need to monitor closely and may require stopping treatment with Aptivus.
Patients taking Aptivus (with ritonavir) may develop severe liver disease that can be life-threatening. The chance of developing liver problems is increased if you have chronic hepatitis B or C infection.
If you are taking oral contraceptives (to prevent pregnancy), you should use additional or different type of contraception.
Aptivus may reduce the effectiveness of oral contraceptives.
If you become pregnant while taking Aptivus tell your doctor immediately.
Contact your doctor immediately if you notice any unusual or unexplained bleeding.
There have been reports of bleeding episodes in people with haemophilia while taking protease inhibitors.
Bleeding in the brain, which can lead to permanent disability or death, has occurred in patients treated with Aptivus in clinical trials. A majority of the patients (experiencing bleeding in the brain) also had other medical conditions or were receiving other medications that may have caused or contributed to bleeding in the brain.
If you have diabetes, tell your doctor if you notice symptoms of high blood glucose levels.
There have been some reports of diabetes and increased blood glucose (hyperglycaemia) in people treated with protease inhibitors. In some of these people this led to ketoacidosis, a serious condition resulting from poorly controlled blood glucose. Some people required adjustments to their diabetes medicines, while others needed new diabetes medicines.
If you have had a previous opportunistic infection, and you notice symptoms of inflammation occurring when you first start taking Aptivus, tell your doctor immediately.
Symptoms of inflammation include redness, swelling, heat and pain. These symptoms have been reported in some patients who have previously had an infection when combination antiretroviral therapy was started.
If you are taking 'statin' medicines to lower your cholesterol level (including atorvastatin), and you notice any muscle pain or weakness not caused by exercise, tell your doctor immediately.
Severe muscle pain and weakness have occurred in people taking protease inhibitors together with cholesterol-lowering medicines called 'statins'.
Do not give Aptivus to anyone else, even if they have the same condition as you.
Do not stop taking Aptivus or change the dose without first checking with your doctor.
Aptivus helps control your HIV infection but does not cure it. Therefore, Aptivus must be taken every day as your doctor prescribed it.
Be careful driving or operating machinery until you know how Aptivus affects you.
Aptivus soft capsules contain small amounts of alcohol (approximately 7% or 100 mg per capsule).
Tell your doctor or pharmacist as soon as possible if you do not feel well while you are taking Aptivus.
It may be difficult to tell whether side effects are the result of taking Aptivus, effects of the HIV disease or side effects of other medicines you may be taking. For this reason, it is very important to inform your doctor of any change in your condition. Your doctor may need to change your dose or advise you to stop taking Aptivus.
All medicines can have side effects. Sometimes they are serious, most of the time they are not. You may need medical treatment if you get some of the side effects.
Ask your doctor or pharmacist to answer any questions you may have.
Do not be alarmed by the following lists of side effects. You may not experience any of them.
The commonly reported side effects in adults are:
Less frequently reported side effects in adults include:
The most frequently reported side effects in children are similar to those described in adults. The frequency of most side effects tends to be lower in children.
Contact your doctor immediately if you experience symptoms of an allergic reaction. You may require urgent medical attention.
Some of the symptoms of an allergic reaction may include:
Cases of hepatitis and severe life-threatening liver dysfunction (such as liver failure) have been reported in patients being treated with Aptivus.
Contact your doctor immediately if you experience any symptoms of liver problems, such as loss of appetite, nausea, vomiting, jaundice (yellowing of the skin and/or eyes), dark coloured urine, pale coloured stools, pain/ache or sensitivity to touch in your right abdominal area (below your ribs).
In some patients, combination antiretroviral therapy may cause changes in body shape due to changes in fat distribution. These may include:
In patients with haemophilia type A and B, there have been reports of increased bleeding while taking protease inhibitors.
Bleeding in the brain has been reported rarely.
Tell your doctor as soon as possible if you experience any side effects during or after taking Aptivus, so that these may be properly treated.
Other side effects not listed above may also occur in some patients.
You should tell your doctor or pharmacist if you notice anything unusual, during or after taking Aptivus.
Bottles of Aptivus soft capsules should be stored in the refrigerator where the temperature stays between 2°C and 8°C. Do not freeze the capsules.
After opening the bottle, the capsules may be stored below 25°C but must be used within 60 days. You should write the date of opening the bottle on the bottle label or outer carton.
Any capsules remaining after 60 days should be returned to your pharmacist for disposal.
Keep your medicine where children cannot reach it.
A locked cupboard at least one-and-a-half metres above the ground is a good place to store medicines.
If your doctor tells you to stop taking this medicine or the expiry date has passed, the unused medicine should be returned to your pharmacist so that it can be disposed of safely.
Aptivus is the brand name of your medicine.
Aptivus soft capsules are pink, oblong, soft gelatin capsules with a black imprint of "TPV 250".
The capsules are supplied in a plastic bottle containing 120 capsules. Each bottle is labelled with the Australian Registration Number AUST R 118104.
Each capsule contains 250 mg tipranavir (active ingredient).
The other ingredients are:
The capsule shell consists of:
Aptivus soft capsules are made in the United States of America (USA) and supplied in Australia by:
BOEHRINGER INGELHEIM PTY LIMITED
ABN 52 000 452 308
78 Waterloo Road
North Ryde NSW 2113
Aptivus® is a registered trademark of Boehringer Ingelheim.
This leaflet was updated in December 2012.
© Boehringer Ingelheim Pty Limited 2012